China Southern Fund Management Co. - CSI Brand Name Drug ETF (SHE:159858)
0.6400
-0.0030 (-0.47%)
May 15, 2026, 4:00 PM EDT
11.11% (1Y)
| Assets | 483.02M |
| Expense Ratio | 0.20% |
| PE Ratio | 32.24 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +11.11% |
| Volume | 18,895,600 |
| Open | 0.6430 |
| Previous Close | 0.6430 |
| Day's Range | 0.6340 - 0.6500 |
| 52-Week Low | 0.5720 |
| 52-Week High | 0.8140 |
| Beta | 0.37 |
| Holdings | n/a |
| Inception Date | Mar 12, 2021 |
About 159858
159858.SZ was created on 2021-03-12 by China Southern. The fund's investment portfolio concentrates primarily on health care equity. Closely track underlying index,Tightly track the target and minimize the deviation
Asset Class Equity
Category Health Care
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 159858
Provider China Southern
Index Tracked CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross
Performance
159858 had a total return of 11.11% in the past year, including dividends. Since the fund's inception, the average annual return has been -7.87%.